Values in Medical Technology
Navigation Links
Values in Medical Technology
... would give approximately 14 mg L-CsA/week. Mean values for C(max) and AUC(0-inf) were up to 20ng/mL and ... leads to highly variable C(max) and AUC(0-12h) values of approximately 1,800ng/mL and 8,000 h ng/mL, ... favorable and significantly lower pharmacokinetic values were obtained for both dose strengths tested. ...
... and were statistically significant achieving p values of <0.0001 and 0.0001, respectively. In Study ... for both primary efficacy endpoints, achieving p values of 0.0075 and <0.0001 for the Evaluator ... Top-line statistical results showed that p values at Month 6 following third injection were ...
... results of the pilot study showed that NT-proBNP values greater than 100 ng/L could be linked to an ... those in the corresponding group with NT-proBNP values <100 ng/L.1 For instance, in the coxib group only 9% of patients with NT-proBNP values <100 ng/L showed CV-AEs compared to 41% ...
... 69 percent (Carb Counting) (P=.70); respective values for A1C <6.5 percent were 44.3 percent and 49.5 ... 2, 6, 12, 18, and 24 (endpoint). Blood glucose values at each visit declined in both arms, and the ... than or equal to 6 months and mean +/- SD A1C values of 8.1 +/- 0.9% (Simplified Algorithm) and 8.3 ...
... 1 hour to five days) and established PI reference values of healthy babies. In establishing reference values that validate possible PI indices for normal vs. ... researchers were able to show that low PI values may correspond to illness. Study results showed ...
... some viral infections by decreasing immunosuppression when ImmuKnow assay values are <100ng/ml or when post-transplant baseline ImmuKnow values decrease by >50%." Among patients who developed elevated viral levels, ...
... data were post-processed for comparison with the reference blood glucose values collected during the study periods. Data were validated for ten subjects ... 98.7%, 100%, and 100% in Study I, II, and III, respectively. Overall MARD values of the three independent studies were between 9.0% and 12.4% -, reflecting ...
... each dosing period. Efficacy was measured objectively by averaging PSG values for N 1/2 and for N 6/7, versus baseline values obtained by averaging results from the screening PSGs. About APD125 ...
... achieved, CGMS readings for the last 24-hour period were recorded and mean values were compared between treatments using a single-tailed, paired t-test. ... medical costs. Results showed that there was no difference in HbA1c values between Levemir and insulin glargine cohorts, and no significant ...
... in Z Kardiol reported that over a two-year period, 80 percent of PT/INR values recorded by mechanical heart valve patients who performed self-testing were in target therapeutic range, compared to only 64.9 percent of PT/INR values monitored by family practitioners.(2) Studies also suggest that PT/INR ...
... analog currently in development for the treatment of chronic HCV infection. PSI-7851 has demonstrated potent in vitro anti-HCV activity with EC(90) values of 31 +/- 12 nM, which is approximately 15-fold more potent than Pharmasset's first generation nucleoside polymerase inhibitor, RG7128 (formerly ...
... ability to obtain or maintain patent or other proprietary intellectual property protection; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred ...
... competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred ...
... in LAA doses in either group. FPG levels (-35.5 +/- 3.3 vs. -20.6 +/- 3.2, p=0.0012) and 1-hour PPG (20.9 +/- 4.79 vs. 40.5 +/- 4.56, CI=0.0022) values were significantly lower with AFRESA than with RAA. Patients in the AFRESA group lost weight (-0.5 +/- 0.3), while patients in the RAA group gained ...
... competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred ...
... than or equal to 90 mm Hg). Twenty-four hour ABPM was performed at baseline and end of study (Week 12). One hundred seventy two patients had ABPM values for baseline and end of study. A total of 134 patients (72.4%) were titrated to AML/OM 10/40 mg. About AZOR (R) AZOR is a convenient, once ...
... investigators at UCLA's David Geffen School of Medicine followed 337 cardiac transplant patients with ImmuKnow to determine whether ImmuKnow assay values can be correlated with the incidence of infection or rejection. The lead investigator, Jon Kobashigawa, MD, favorably remarked, "These results ...
... Specifically, the efficacy outcomes were statistically significantly different when comparing GLYC-101 0.1% and GLYC-101 1.0% groups to placebo ( p values are 0.0062 and 0.0331, respectively). These interim results suggest that the time to wound closure will be shorter for eyelids treated on the active ...
... competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred to in ...
... competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred ...
... competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred ...
... competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred ...
... curves for each plate run (n=14) showed an average slope is -3.37 with a 95 percent confidence interval of (-3.47, -3.27) with all R-squared values are above 0.99 with the exception of one plate. About IntelligentMDx IntelligentMDx's mission is to make FDA approved diagnostic kits. ...
... competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred ...
... competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred ...
... competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred ...
... competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred ...
... protection; competition in general; government, industry and general public pricing pressures the effect that the foregoing factors could have on the values attributed to the Group's assets and liabilities as recorded in the Group's consolidated balance sheet; and other risks and factors referred to in ...
... significantly improved CFTR-mediated chloride channel activity as measured by nasal potential difference, with 40 percent of patients achieving values in the normal range during PTC124 administration. The study demonstrated improvements in patients with multiple nonsense mutation types and indicated ...
... and were statistically significant achieving p values of <0.0001 and 0.0001, respectively. In Study ... for both primary efficacy endpoints, achieving p values of 0.0075 and <0.0001 for the Evaluator ... Top-line statistical results showed that p values at Month 6 following third injection were ...
... results of the pilot study showed that NT-proBNP values greater than 100 ng/L could be linked to an ... those in the corresponding group with NT-proBNP values <100 ng/L.1 For instance, in the coxib group only 9% of patients with NT-proBNP values <100 ng/L showed CV-AEs compared to 41% ...
... 69 percent (Carb Counting) (P=.70); respective values for A1C <6.5 percent were 44.3 percent and 49.5 ... 2, 6, 12, 18, and 24 (endpoint). Blood glucose values at each visit declined in both arms, and the ... than or equal to 6 months and mean +/- SD A1C values of 8.1 +/- 0.9% (Simplified Algorithm) and 8.3 ...
... 1 hour to five days) and established PI reference values of healthy babies. In establishing reference values that validate possible PI indices for normal vs. ... researchers were able to show that low PI values may correspond to illness. Study results showed ...
... some viral infections by decreasing immunosuppression when ImmuKnow assay values are <100ng/ml or when post-transplant baseline ImmuKnow values decrease by >50%." Among patients who developed elevated viral levels, ...
Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders
... treatment. No SAEs occurred during 100% HPN-100 treatment. Ammonia values were ~30% lower on HPN-100 assessed as TNAUC over 24 hours [mean (SD) = ... or the percentage of normal values: 58% vs. 72%]. Differences in ammonia values were not statistically significant. "We are very pleased with the ...NicOx' Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis
... methods used to make these comparisons (see NOTE 2). The calculation of p values was not planned, although they have been included in this press release ... and assuming heterogeneous (non constant) within study variance. P values for categorized changes from baseline are based on the same mixed model ...... data were post-processed for comparison with the reference blood glucose values collected during the study periods. Data were validated for ten subjects ... 98.7%, 100%, and 100% in Study I, II, and III, respectively. Overall MARD values of the three independent studies were between 9.0% and 12.4% -, reflecting ...
... each dosing period. Efficacy was measured objectively by averaging PSG values for N 1/2 and for N 6/7, versus baseline values obtained by averaging results from the screening PSGs. About APD125 ...
... achieved, CGMS readings for the last 24-hour period were recorded and mean values were compared between treatments using a single-tailed, paired t-test. ... medical costs. Results showed that there was no difference in HbA1c values between Levemir and insulin glargine cohorts, and no significant ...
... in Z Kardiol reported that over a two-year period, 80 percent of PT/INR values recorded by mechanical heart valve patients who performed self-testing were in target therapeutic range, compared to only 64.9 percent of PT/INR values monitored by family practitioners.(2) Studies also suggest that PT/INR ...
Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale d'Urologie
... IPSS Quality of Life (QoL), IPSS improvement by > 30% and > 40%, uroflow values (Qmax), PVR and prostate volume at time points up to 28 weeks. Safety ... changes in erectile function (IIEF-5), treatment emergent AEs, lab values (including testosterone, PSA) and vital signs. Mean age was 69.1 (range 52 ...... analog currently in development for the treatment of chronic HCV infection. PSI-7851 has demonstrated potent in vitro anti-HCV activity with EC(90) values of 31 +/- 12 nM, which is approximately 15-fold more potent than Pharmasset's first generation nucleoside polymerase inhibitor, RG7128 (formerly ...
Injection Reverses Heart-Attack Damage
... for children, Children ' s Hospital Boston today is a 397-bed comprehensive center for pediatric and adolescent health care grounded in the values of excellence in patient care and sensitivity to the complex needs and diversity of children and families. Children ' s also is the primary ...... ability to obtain or maintain patent or other proprietary intellectual property protection; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred ...
Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial
... 100 mg bid 152 101 (66%) 65 (43%) 43 (28%) 41 (27%) p<0.001 p<0.001 p<0.001 <0.001 p values compared to placebo Note: At 6 months. All patients were on stable doses of methotrexate throughout the clinical trial. * The results ...... competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred ...
... in LAA doses in either group. FPG levels (-35.5 +/- 3.3 vs. -20.6 +/- 3.2, p=0.0012) and 1-hour PPG (20.9 +/- 4.79 vs. 40.5 +/- 4.56, CI=0.0022) values were significantly lower with AFRESA than with RAA. Patients in the AFRESA group lost weight (-0.5 +/- 0.3), while patients in the RAA group gained ...
... competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred ...
... than or equal to 90 mm Hg). Twenty-four hour ABPM was performed at baseline and end of study (Week 12). One hundred seventy two patients had ABPM values for baseline and end of study. A total of 134 patients (72.4%) were titrated to AML/OM 10/40 mg. About AZOR (R) AZOR is a convenient, once ...
... investigators at UCLA's David Geffen School of Medicine followed 337 cardiac transplant patients with ImmuKnow to determine whether ImmuKnow assay values can be correlated with the incidence of infection or rejection. The lead investigator, Jon Kobashigawa, MD, favorably remarked, "These results ...
... Specifically, the efficacy outcomes were statistically significantly different when comparing GLYC-101 0.1% and GLYC-101 1.0% groups to placebo ( p values are 0.0062 and 0.0331, respectively). These interim results suggest that the time to wound closure will be shorter for eyelids treated on the active ...
Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)
... analog currently in developed for the treatment of chronic HCV infection. PSI-7851 has demonstrated in vitro anti-HCV activity with EC(50) values of 90 +/- 60 nM, which is approximately 15- to 20-fold more potent than the active metabolite of Pharmasset's first generation nucleoside polymerase ...... competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred to in ...
... competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred ...
Breast Cancer Clinical Results Show Test Can Differentiate Normal, Early and Later Stage Cancers
... Nipple Aspirate Fluid may distinguish women with or without Breast Cancer" concluded by stating that "GOS reactivity as measured by adjusted chroma values are significantly different between normal patients, those with Ductal Carcenoma In Situ and those with invasive cancer" and that "these results ...DNA Therapeutics Closes 2.2 Million EUR Series A Financing Round
... SEFTI that is strongly committed to support Life Science innovation at early stage in France and in Europe, and that shares our business vision and values the potential of our drug development based on our unique proprietary siDNA technology. This financing will allow DNA Therapeutics to move ahead with ...... competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred ...
... competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred ...
... curves for each plate run (n=14) showed an average slope is -3.37 with a 95 percent confidence interval of (-3.47, -3.27) with all R-squared values are above 0.99 with the exception of one plate. About IntelligentMDx IntelligentMDx's mission is to make FDA approved diagnostic kits. ...
... competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred ...
... competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred ...
... competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred ...
... competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred ...
Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials
... the Cervista 16/18 test results were compared to CIN2 and CIN3 clinical end-points. Two potentially important findings were Negative Predictive values for 99.5% for CIN3 and 97.7% for CIN2+. Recent consensus guidelines released by the American Society for Colposcopy and Cervical Pathology (ASCCP) in ...New Analysis Shows Troubling Trend in Triglyceride Levels May Be Linked to Rising Rates of Obesity
... 74 years who took the blood lipid examination were selected from NHANES II (1976-1980), NHANES III (1988-1994), and NHANES 1999-2006. Adults missing values on total cholesterol, HDL cholesterol or triglycerides were excluded. Where LDL was missing, the Friedewald equation was used to calculate LDL for ...... protection; competition in general; government, industry and general public pricing pressures the effect that the foregoing factors could have on the values attributed to the Group's assets and liabilities as recorded in the Group's consolidated balance sheet; and other risks and factors referred to in ...
FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes
... in the glulisine group and 8.37% (+ or - 1.32) in the lispro group. Postprandial glycemic control, as assessed by the self-monitored blood glucose values and blood glucose excursions, was similar in both treatment groups at endpoint. No noteworthy differences existed between treatment groups in ...... significantly improved CFTR-mediated chloride channel activity as measured by nasal potential difference, with 40 percent of patients achieving values in the normal range during PTC124 administration. The study demonstrated improvements in patients with multiple nonsense mutation types and indicated ...
Other ContentstrenchtremortremortremortrichomoniasisneuralgianeuralgiatrigeminaltrigeminalatresiasprueOther TagsKhoslaMinusMinusAdjustableClassicDermatome
(Date:12/16/2009)... of financial and technical assistance to developing countries around ... to be connected to space technology, but large development ... linked. , Global climate change is also an increasingly ... the poorest countries and communities, which will suffer the ... to a growing demand for information about the state ...
(Date:12/16/2009)... seasonal exposure to pesticides in rivers and basins ... salmon populations. In addition to the widespread deterioration ... to commonly used pesticides may further inhibit the ... "Major efforts are currently underway to restore Pacific ... populations," says David Baldwin of the National Oceanic ...
(Date:12/16/2009)... University of Maryland School of Medicine researcher will lead ... most prominent scientists in the field of stem cell ... Preventive Medicine, was chosen by the National Heart, Lung ... this consortium of national experts, which will be called ... will be funded by a $30 million grant over ...
Breaking Biology News(10 mins):ESA and World Bank move toward closer collaboration 2ESA and World Bank move toward closer collaboration 3ESA and World Bank move toward closer collaboration 4Even at sublethal levels, pesticides may slow the recovery of wild salmon populations 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 3Rib X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital 6988 1Rib X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital 6988 2Rib X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital 6988 3For Breast Cancer Treatment an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastins Dominance in Europe 6985 1For Breast Cancer Treatment an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastins Dominance in Europe 6985 2For Breast Cancer Treatment an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastins Dominance in Europe 6985 3Accumetrics Closes 2009 with Positive Outlook 6982 1Accumetrics Closes 2009 with Positive Outlook 6982 2Accumetrics Closes 2009 with Positive Outlook 6982 3(Date:12/16/2009)... 16 In a random sampling of ... ME, and Philadelphia, PA, numerous pallets tested positive ... that could potentially create health hazards for consumers. ... previous wood pallet testing conducted in the Washington-Baltimore ... risks to our nation,s food supply from wood ...
(Date:12/16/2009)... heart of diagnostic procedures in cardiology. The idea of ... the expertise of European cardiovascular imagers, is therefore long ... is written with a patient rather than technology-based approach, ... with the aid of imaging. , The book ... theory and practice of cardiac imaging and its clinical ...
(Date:12/16/2009)... families of sick and dying hospitalized children ask their ... do pediatricians respond to such personal requests? While increasing ... some patients and families cope with serious illness, a ... families and patients who raise the issue of prayer, ... of Southern Medical Journal , Brandeis and Rice ...
(Date:12/16/2009)... Medical Solutions, a national healthcare staffing agency, is honored to ... as the company’s Recruiters of the Year in Healthcare Traveler ... second consecutive year that Chris has received such honors and ... ... (PRWEB) December 16, 2009 -- Medical Solutions, a national healthcare ...
(Date:12/16/2009)... from around the world have visited Israel,s Dead Sea ... reputation that dates back over 2000 years, and legend ... introduction of two bath salt lines from SaltWorks ( ... Dead Sea salt in their own homes. ,, SaltWorks, ... and essential oils - but no artificial colors or ...
Breaking Medicine News(10 mins):Health News:New Tests Confirm Wood Pallets Harbor Deadly Food Poisoning Bacteria 2Health News:New Tests Confirm Wood Pallets Harbor Deadly Food Poisoning Bacteria 3Health News:New Tests Confirm Wood Pallets Harbor Deadly Food Poisoning Bacteria 4Health News:The European Society of Cardiology Textbook of Cardiovascular Imaging puts patient at center 2Health News:The European Society of Cardiology Textbook of Cardiovascular Imaging puts patient at center 3Health News:Prayer on the hospital floor 2Health News:Medical Solutions is Proud to Announce Chris Wepfer and Jackie Kirby as the Company's Recruiter of the Year Recipients 2Health News:Medical Solutions is Proud to Announce Chris Wepfer and Jackie Kirby as the Company's Recruiter of the Year Recipients 3Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 2Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 3[0] New Tests Confirm Wood Pallets Harbor Deadly Food Poisoning Bacteria[0] The European Society of Cardiology Textbook of Cardiovascular Imaging puts patient at center[1] Prayer on the hospital floor[0] Medical Solutions is Proud to Announce Chris Wepfer and Jackie Kirby as the Company's Recruiter of the Year Recipients [0] SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea
KhoslaMinusAdjustableGraftonClassicMucotomeFresnelDermatomeBANGOLINIAlgerbrushMaltzmanDietzClasenGuimaraes
Other Tagsspells 2blocks 2blocks 3blocks 4blocks 5blocks 6blocks 7blocks 8blocks 9blocks 10silencing 2managers 2assistance 2assistance 3financial 2financial 3| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |